510(k) Report

FDA applicant

Insulet Corporation

Acton, MA25 decisions2003–202623 recalls

FDA records 25 decisions for Insulet Corporation (Acton, MA) from 2003 to 2026: 25 510(k) clearances. Most are in product codes LZG (Pump, Infusion, Insulin) and QJI (Interoperable Automated Glycemic Controller). Since 2016 its 510(k)s took a median of 103 days from receipt to decision, against 140 for FDA’s reviews in the same codes and years. Its devices cite 24 predicates, 20 of them its own earlier devices. 23 recalls are linked to its devices, 10 Class I.

FDA’s records also spell it “Insulet Corp.”.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, general hospital panel, where it files most

How often FDA has decided Insulet Corporation’s devices, and how often a recall has named them.

FDA decisions per year

1in 2025

2011: 12012: 12013: 12014: 12016: 12017: 12018: 12019: 32021: 12022: 52023: 32024: 22025: 12026 (partial year): 1
2007high 5 (2022) · low 0 (2007)2026

2026 so far, outlined.

Recalls per year

4in 2026

2013: 22015: 6, 4 Class I2018: 12020: 32021: 12022: 2, 1 Class I2023: 2, 1 Class I2025: 22026 (partial year): 4, 4 Class I
2007high 6 (2015) · low 0 (2007)2026

Class I Class II/III not classified

FIG. 1 — Insulet Corporation by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Insulet Corporation’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report